Übersichtsarbeit
Neoadjuvant Therapy for Melanoma
Advances in Surgery · 2026-09 · 60 (1) · 85-97
DOI: 10.1016/j.yasu.2026.03.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Surgery, 2026-09. Verfasst von Margaret H O'Connor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University Medical Center, Durham, NC, USA. Hauptthemen laut MEDLINE: Melanoma, Neoadjuvant Therapy, Skin Neoplasms, Immunotherapy. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
MelanomaNeoadjuvant TherapySkin NeoplasmsImmunotherapyHumansImmune Checkpoint InhibitorsMolecular Targeted Therapy
Stichwörter der Autor:innen
Immune checkpoint inhibitorMelanomaNeoadjuvant therapyTargeted therapy
Substanzen
Immune Checkpoint Inhibitors
Autor:innen und Institutionen
- Department of Surgery, Duke University Medical Center, Durham, NC, USA.
- Department of Surgery, Duke University, Durham, NC, USA.
- Department of Surgery, Duke University Medical Center, Durham, NC, USA. Electronic address: Georgia.Beasley@duke.edu.
Zitieren
APA
O'Connor, M. H., DeLaura, I., & Beasley, G. M. (2026). Neoadjuvant Therapy for Melanoma. Advances in Surgery, 60(1), 85-97. https://doi.org/10.1016/j.yasu.2026.03.005
Vancouver
O'Connor MH, DeLaura I, Beasley GM. Neoadjuvant Therapy for Melanoma. Advances in Surgery. 2026;60(1):85-97. doi:10.1016/j.yasu.2026.03.005
BibTeX
@article{OConnor2026,
author = {O'Connor, Margaret H and DeLaura, Isabel and Beasley, Georgia M},
title = {Neoadjuvant Therapy for Melanoma},
journal = {Advances in Surgery},
year = {2026},
volume = {60},
number = {1},
pages = {85--97},
doi = {10.1016/j.yasu.2026.03.005}
}
EUVIMED